PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor Progression

This study aimed to investigate the role of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 2 (PLOD2) in glioblastoma (GBM) pathophysiology. To this end, PLOD2 protein expression was assessed by immunohistochemistry in two independent cohorts of patients with primary GBM (n(1) = 204 and n(2) = 203,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreße, Nina, Schröder, Hannah, Stein, Klaus-Peter, Wilkens, Ludwig, Mawrin, Christian, Sandalcioglu, Ibrahim Erol, Dumitru, Claudia Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181500/
https://www.ncbi.nlm.nih.gov/pubmed/35682709
http://dx.doi.org/10.3390/ijms23116037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181500/
https://www.ncbi.nlm.nih.gov/pubmed/35682709
http://dx.doi.org/10.3390/ijms23116037

Ejemplares similares